AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21236344
Drug: exemestane (EXE)
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: exemestane (EXE) 25 mg daily (group B)
Trial: 21236344
Drug: letrozole (LET)
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: letrozole (LET) 2.5 mg daily (group C)
Trial: 8472625
Drug: Subcutaneous human
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous human proinsulin
Trial: 8472625
Drug: Insulin zinc
RxNorm normalized name: insulin zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin zinc suspension
Trial: 31305949
Drug: Existing treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Existing treatment (control group)
Trial: 27165587
Drug: PS +
RxNorm normalized name: Spartan Nash 32 gauge 4 mm Pen Tips + 1C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PS + continuous inhalation of budesonide aerosol
Trial: 27165587
Drug: PS +
RxNorm normalized name: Spartan Nash 32 gauge 4 mm Pen Tips + 1C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PS + budesonide solution
Trial: 20962212
Drug: Canakinumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canakinumab (300 mg, subcutaneously)
Trial: 17490781
Drug: Adjusted OAD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjusted OAD therapy
Trial: 15699946
Drug: Cardioversion with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardioversion with subsequent use of antiarrhythmic drugs for maintenance of sinus rhythm
Trial: 15699946
Drug: Antithrombotic drugs
RxNorm normalized name: Heparin group antithrombotic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithrombotic drugs (warfarin and aspirin)
Trial: 15124545
Drug: Thermo-sensitive liposomes
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermo-sensitive liposomes for carrying and targeting chemotherapeutics and gene therapies
Trial: 19571282
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg daily)
Trial: 15177063
Drug: Propranolol (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (180 mg daily)
Trial: 11121909
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg o.m. and tinidazole 500 mg b.d. during the first 3 days of pantoprazole therapy (early group, n=50)
Trial: 11121909
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg o.m. and tinidazole 500 mg b.d. during the last 3 days of pantoprazole therapy (late group, n=50)
Trial: 1532117
Drug: Procaterol aerosol
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol aerosol (10 micrograms/inhalation), 2 inhalations t.i.d.
Trial: 1532117
Drug: Albuterol (salbutamol)
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (salbutamol) aerosol (100 micrograms/inhalation), 2 inhalations t.i.d.
Trial: 30099422
Drug: Basic medical
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic medical treatment and allergen-specific immunotherapy (ASIT)
Trial: 30099422
Drug: Basic medical
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic medical treatment only
Trial: 8869763
Drug: Low-dose morphine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose morphine
Trial: 20441717
Drug: Olanzapine OST
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine OST (10 mg od, 8 days)
Trial: 15828904
Drug: Oral calcium
RxNorm normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcium carbonate plus vitamin D sterol (calcitriol or alfacalcidol)
Trial: 9917117
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation self-management group based on a structured treatment and teaching program and INR self-monitoring
Trial: 35406
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (TRH), 40 mg single dose
Trial: 29798207
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray allergen blocker combined with oral antihistamine (citrate tablets)
Trial: 27565398
Drug: Smoking Treatment
RxNorm normalized name: Pipe smoking tobacco
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking Treatment and Anxiety Management Program (STAMP)
Trial: 15164511
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (ST) + placebo
Trial: 11668360
Drug: Dipyrone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone (600 mg oral dose)
Trial: 9482291
Drug: High-dose isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose isosorbide dinitrate (3 mg bolus administered intravenously every 5 min)
Trial: 9482291
Drug: High-dose furosemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose furosemide plus low-dose isosorbide dinitrate
Trial: 9482291
Drug: High-dose isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose isosorbide dinitrate
Trial: 8305277
Drug: Gadodiamide injection
RxNorm normalized name: Gadodiamide
DrugBank: Gadodiamide (DB00225)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadodiamide injection at a dose of 0.3 mM/kg (n = 7)
Trial: 8305277
Drug: Gadopentetate dimeglumine
RxNorm normalized name: Gadopentetate Dimeglumine
DrugBank: Gadopentetic acid (DB00789)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadopentetate dimeglumine at a dose of 0.1 mM/kg (n = 6)
Trial: 3071485
Drug: Diet plus
RxNorm normalized name: Glucomannan/Grapefruit Extract/Pyridoxine Oral Tablet [GRAPEFRUIT DIET PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet plus moderate exercise (3-mile walk, twice a week group sessions, once a week individual sessions)
Trial: 29982544
Drug: Combined 2
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined 2 × 1000 mg/d omega-3 fatty acid and 50,000 IU/biweekly cholecalciferol supplement
Trial: 27046347
Drug: Stent-retriever thrombectomy
RxNorm normalized name: castor fiber scent gland secretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stent-retriever thrombectomy in combination with IV t-PA
Trial: 22512875
Drug: Inorganic sunscreen
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inorganic sunscreen with SPF 8 at 0 mg cm(‐2) thickness
Trial: 22512875
Drug: Inorganic sunscreen
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inorganic sunscreen with SPF 8 at 1 mg cm(‐2) thickness
Trial: 22512875
Drug: Inorganic sunscreen
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inorganic sunscreen with SPF 8 at 1.5 mg cm(‐2) thickness
Trial: 12126264
Drug: Telmisartan monotherapy
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan monotherapy (40 or 80 mg)
Trial: 12126264
Drug: Telmisartan +
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan + HCTZ 12.5 mg
Trial: 12126264
Drug: Telmisartan +
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan + HCTZ 25 mg
Trial: 12126264
Drug: Telmisartan +
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan + another antihypertensive + HCTZ
Trial: 12126264
Drug: Telmisartan monotherapy
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan monotherapy
Trial: 1701072
Drug: Aprotinin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (2 x 10(6) KIU bolus before surgery, continuous infusion of 5 x 10(5) KIU/h during surgery, and additional 2 x 10(6) KIU to pump prime)
Trial: 28732519
Drug: General skin-care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General skin-care advice plus emollients applied daily for the first year of life
Trial: 20361905
Drug: Olanzapine/fluoxetine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine/fluoxetine combination
Trial: 10067662
Drug: L-carnitine (0.28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (0.28 micromole/kg bw/minute)
Trial: 321005
Drug: Parenteral penicillin
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parenteral penicillin
Trial: 29202549
Drug: Clonidine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.5 to 2.0 mg orally)
Trial: 19596415
Drug: H5N1 inactivated
RxNorm normalized name: influenza, H5N1-1203
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H5N1 inactivated subvirion vaccine
Trial: 15349011
Drug: Paroxetine 20
RxNorm normalized name: PARoxetine 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 20 mg/d for 18 days
Trial: 2443619
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) 450 mg/m2 IV bolus daily for five days, then 200 mg/m2 IV bolus every other day for six doses
Trial: 2443619
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 50 mg/m2 IV infusion over four hours followed by IV bolus of 5-FU 600 mg/m2 weekly for 4 weeks and then every 2 weeks
Trial: 2443619
Drug: Leucovorin 500
RxNorm normalized name: leucovorin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leucovorin 500 mg/m2 IV infusion with 5-FU 600 mg/m2 IV bolus one hour after Leucovorin every week for 6 weeks
Trial: 21885490
Drug: VLD cyclobenzaprine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VLD cyclobenzaprine (CBP) 1-4 mg at bedtime
Trial: 9360512
Drug: [norleucine27]GHRH (1-29)-NH2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [norleucine27]GHRH (1-29)-NH2 at a dose of 10 micrograms/kg
Trial: 25170226
Drug: 160 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg/d PI-88
Trial: 20719465
Drug: Bivalirudin (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin (0.75 mg/kg intravenous bolus and intraprocedural infusion at 1.75 mg/kg/h)
Trial: 20719465
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (100 UI/kg)
Trial: 12526285
Drug: Tamsulosin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.2 mg) once daily for 24 weeks
Trial: 12526285
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg) once daily for 24 weeks
Trial: 12526285
Drug: Tamsulosin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.2 mg) at 4 weeks
Trial: 12526285
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg) at 4 weeks
Trial: 2248062
Drug: Moclobemide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (100 mg)
Trial: 2248062
Drug: Moclobemide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (200 mg, 3 times daily)
Trial: 2248062
Drug: Alcohol (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.6 g/l)
Trial: 23183751
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (1200 IU), folic acid (0.5 mg), vitamin B12 (0.5 mg), vitamin B6 (50 mg), and calcium carbonate (456 mg) (group A)
Trial: 21721475
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement (standard multivitamin formula with phytonutrients); details on dosage and duration not specified.
Trial: 17922899
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg Nicotinell lozenge
Trial: 6138071
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg midazolam
Trial: 1587067
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg ephedrine
Trial: 3886400
Drug: Urapidil 30
RxNorm normalized name: urapidil 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil 30 mg b.i.d.
Trial: 3886400
Drug: Clonidine 0.075-0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.075-0.15 mg b.i.d.
Trial: 29468978
Drug: Echium amoenum
RxNorm normalized name: Echium plantagineum seed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Echium amoenum compound syrup (EACS)
Trial: 29468978
Drug: Citalopram tablet
RxNorm normalized name: Citalopram Tablets
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram tablet
Trial: 27175680
Drug: Dexmedetomidine (DEX)
DrugBank: Dexmedetomidine (DB00633)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexmedetomidine (DEX) 0.25 μg/kg/h diluted to 100 mL in 0.9% saline
Trial: 16418872
Drug: Ibuprofen 600
RxNorm normalized name: ibuprofen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 600 mg t.i.d.
Trial: 18477491
Drug: Conventional regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional regimen (13 cycles with 21 days of treatment + 7 days without hormones)
Trial: 18477491
Drug: Extended-cycle regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-cycle regimen (four extended cycles with 84 days of continuous administration of EE/DNG, followed by a hormone-free interval of 7 days)
Trial: 15816785
Drug: mirtazapine 30
RxNorm normalized name: mirtazapine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mirtazapine 30 mg
Trial: 15816785
Drug: escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: escitalopram 10 mg and 20 mg
Trial: 8777303
Drug: Lansoprazole 15
RxNorm normalized name: lansoprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 15 mg bd + Amoxicillin 750 mg bd + Metronidazole 500 mg bd
Trial: 1647185
Drug: Radiotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy with 30 mg/m2 cisplatin once a week
Trial: 1647185
Drug: Radiotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy with 6 mg/m2 cisplatin daily
Trial: 24557088
Drug: Dutasteride (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride (4 mg)
Trial: 23251997
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous lidocaine infusion of 2 mg/kg/h
Trial: 15777307
Drug: Clonidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (150 microg) as adjuvant for lidocaine (40 ml of lidocaine at 10 mg/ml)
Trial: 15777307
Drug: Lidocaine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (40 ml of lidocaine at 10 mg/ml) with saline
Trial: 31996186
Drug: 200 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/kg bovine lactoferrin (bLF) in breast/donor human milk or formula milk until 34 weeks corrected gestation or for a minimum of 2 weeks, whichever is longer, or until discharge home or transfer, if earlier
Trial: 31996186
Drug: No bovine
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No bovine lactoferrin (bLF) with daily feeds
Trial: 11434597
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha (IFN-α) alone (group A)
Trial: 11434597
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon alpha (IFN-α) with ribavirin (group B)
Trial: 11732520
Drug: Erythromycin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (200 mg) given 3 hours before induction of anaesthesia
Trial: 11732520
Drug: Erythromycin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (200 mg) given 1 hour before induction of anaesthesia
Trial: 11732520
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nothing with 10 ml water)
Trial: 7014656
Drug: Pentazocine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine (50 mg)
Trial: 1550907
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg t.i.d.
Trial: 1550907
Drug: 350 mg
RxNorm normalized name: hemin 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg b.i.d.
Trial: 1550907
Drug: 350 mg
RxNorm normalized name: hemin 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg t.i.d.
Trial: 3926229
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with iodine-131 or carbimazole in hyperthyroid patients
Trial: 3926229
Drug: Thyroxine replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroxine replacement therapy in hypothyroid patients
Trial: 3926229
Drug: Standard doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard doses of thyroxine replacement therapy in hypothyroid patients
Trial: 10102947
Drug: 7-day triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day triple therapy with amoxycillin 1000 mg b.d., clarithromycin 500 mg b.d., and lansoprazole 30 mg b.d.
Trial: 10102947
Drug: 7-day triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day triple therapy (same as above) for re-treatment of patients who failed 1-day treatment.
Trial: 31793529
Drug: Frinozol nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frinozol nasal spray (Phenylephrine + Cetyrizine)
Trial: 28202383
Drug: Tailored program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored program of physical therapy
Trial: 21949991
Drug: 10 microg
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 microg Alprostadil injection by vein, once a day for 14 days (Group B)
Trial: 11564829
Drug: IL-10 administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-10 administered subcutaneously for 28 days
Trial: 9563670
Drug: Fluticasone Propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone Propionate Aqueous Nasal Spray (FPANS)
Trial: 28320220
Drug: Combined treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatments (Yiqiqubai granule + 308-nm excimer laser)
Trial: 24930619
Drug: Radioembolization with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioembolization with yttrium-90 resin microspheres followed by sorafenib (200 mg twice daily escalating to 400 mg twice daily)
Trial: 24930619
Drug: Sorafenib only
RxNorm normalized name: Sorafenib only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib only (matching dose schedule to the intervention arm)
Trial: 16877419
Drug: Nimodipine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (30 mg three times a day for two periods of 5 days)
Trial: 10718775
Drug: Subcutaneous infusion
RxNorm normalized name: subcutaneous infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous infusion morphine (5 mg)
Trial: 1525789
Drug: Cisapride 5
RxNorm normalized name: cisapride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 5 mg TID
Trial: 3885848
Drug: 0.1 ml
RxNorm normalized name: ethanol 0.1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 ml of intradermal BCG vaccine
Trial: 26677350
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (30 g)
Trial: 16497643
Drug: Non-treatment (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment (control group) at 3 years
Trial: 11565517
Drug: Irbesartan (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (300 mg daily)
Trial: 3327677
Drug: Moduretic (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moduretic (after dose increase)
Trial: 9103485
Drug: Hydrocodone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocodone (10 mg, 15 mg, and 22.5 mg p.o.) after placebo or quinidine (100 mg) pretreatment
Trial: 9103485
Drug: Quinidine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (100 mg) pretreatment
Trial: 7942523
Drug: t‐PA plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: t‐PA plus saline solution (group 1)
Trial: 3035878
Drug: Zimeldine, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimeldine, 100 mg, b.i.d., n = 40